|
221 |
Armas Rojas N.B., Lacey B., Simadibrata D.M., Ross S., Varona-Pérez P., Burrett J.A., Calderón Martínez M., Lorenzo-Vázquez E., Bess Constantén S., Thomson B., Sherliker P., Morales Rigau J.M., Carter J., Massa M.S., Hernández López O.J., Islam N., Martínez Morales M.Á., Alonso Alomá I., Achiong Estupiñan F., Díaz González M., Rosquete Muñoz N., Cendra Asencio M., Emberson J., Peto R., Lewington S. |
Alcohol consumption and cause-specific mortality in Cuba: prospective study of 120 623 adults |
EClinicalMedicine |
|
National Institute of Cardiology and Cardiovascular Surgery, Havana, Cuba; Nuffield Department of Population Health (NDPH), University of Oxford, United Kingdom; Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Institute of Hygiene, Epidemiology and Microbiology, Ministry of Public Health, Havana, Cuba; Cuban Commission Against Smoking, Ministry of Public Health, Havana, Cuba; Directorate of Medical Records and Health Statistics, Ministry of Public Health, Havana, Cuba; George Institute for Global Health, University of Oxford, United Kingdom; MRC Population Heath Research Unit, NDPH, University of Oxford, United Kingdom; Provincial Center of Hygiene, Epidemiology and Microbiology, Matanzas, Cuba; Municipal Center of Hygiene, Epidemiology and Microbiology, Jagüey Grande, Matanzas, Cuba; Municipal Center of Hygiene, Epidemiology and Microbiology, ColónMatanzas, Cuba; Municipal Center of Hygiene, Epidemiology and Microbiology, Camagüey, Cuba; MRC UKM Medical Molecular Biology Institute (UMBI), NDPH, Malaysia |
Lancet Publishing Group |
Article |
Q1 |
|
|
|
225 |
Lamontagne F., Agoritsas T., Siemieniuk R., Rochwerg B., Bartoszko J., Askie L., MacDonald H., Amin W., Bausch F.J., Burhan E., Cecconi M., Chanda D., Dat V.Q., Du B., Geduld H., Gee P., Nerina H., Hashimi M., Hunt B.J., Kabra S., Kanda S., Kawano-Dourado L., Kim Y.-J., Kissoon N., Kwizera A., Leo Y.-S., Mahaka I., Manai H., Mino G., Nsutebu E., Pshenichnaya N., Qadir N., Ranganathan S.S., Sabzwari S., Sarin R., Sharland M., Shen Y., Souza J.P., Stegemann M., Ugarte S., Venkatapuram S., Vuyiseka D., Preller J., Brignardello-Petersen R., Kum E., Qasim A., Zeraatkar D., Owen A., Guyatt G., Lytvyn L., Diaz J., Vandvik P.O., Jacobs M. |
A living WHO guideline on drugs to prevent covid-19 |
The BMJ |
10 |
Université de Sherbrooke, Centre de Recherche Due Chu de Sherbrooke, Sherbrooke, QC, Canada; Division of General Internal Medicine, Division of Clinical Epidemiology, University Hospitals of Geneva, Geneva, Switzerland; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada; Magic Evidence Ecosystem Foundation, Oslo, Norway; Department of Medicine, McMaster University, Hamilton, ON, Canada; World Health Organization, Geneva, Switzerland; The Bmj, London, United Kingdom; Ministry of Health and Population, Cairo, Egypt; Geneva University Hospital, Switzerland; Infection Division, Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Indonesia, Indonesia; Department of Anesthesia and Intensive Care Medicine, Humanitas Clinical and Research Center-IRCCS, Rozzano, Italy; Adult Infectious Disease Centre, University Teaching Hospital, Lusaka, Zambia; Department of Infectious Diseases, Hanoi Medical University, Hanoi, Viet Nam; Peking Union Medical College Hospital, Beijing, China; Division of Emergency Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa; United States; Royal Melbourne Hospital, Melbourne, Australia; Ziauddin University, Karachi, Pakistan; Guy's and St Thomas' Nhs Foundation Trust, London, United Kingdom; All India Institute of Medical Sciences, New Delhi, India; McMaster University (Alumnus), Canada; Pulmonary Division, Heart Institute (InCor)- Hcfmusp, Medical School, University of Sao Paulo, São Paulo, Brazil; Sungkyunkwan University, School of Medicine, Samsung Medical Center, Seoul, South Korea; Department of Paediatrics and Emergency Medicine, University of British Columbia, Vancouver, Canada; Department of Anaesthesia and Critical Care, College of Health Sciences, Makerere University, Kampala, Uganda; National Center for Infectious Diseases, Singapore, Singapore; Pangaea Harare, Zimbabwe; Emergency Medical Services, Faculty of Medicine, Tunis, Tunisia; Alcivar Hospital, Guayaquil, Ecuador; Sheikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates; Central Research Institute of Epidemiology of Rospotrebnadzor, Moscow, Russian Federation; Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, United States; University of Colombo, Colombo, Sri Lanka; Aga Khan University, Karachi, Pakistan; National Institute of Tuberculosis and Respiratory Diseases, New Delhi, India; St. George's University Hospital, London, United Kingdom; Shanghai Public Health Clinical Center, Fudan University, Shanghai, China; University of Sao Paulo, Sao Paulo, Brazil; Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Department of Infectious Diseases and Respiratory Medicine, Berlin, Germany; Faculty of Medicine, Andres Bello University, Indisa Clinic, Santiago, Chile; King's College, London, United Kingdom; University of Stellenbosch, South Africa; University of Liverpool, Liverpool, United Kingdom; Department of Health Economics and Health Management, Institute for Health and Society, University of Oslo, Oslo, Norway; Royal Free London Nhs Foundation Trust, London, United Kingdom; Research Institute, Hospital Do Coração (HCor), São Paulo, Brazil |
BMJ Publishing Group |
Review |
Q1 |
|
|
|
226 |
Zeziulin O., Mollan K.R., Shook-Sa B.E., Hanscom B., Lancaster K.E., Dumchev K., Go V.F., Chu V.A., Kiriazova T., Syarif Z., Dvoryak S., Reifeis S.A., Hamilton E., Sarasvita R., Rose S., Richardson P., Clarke W., Latkin C.A., Metzger D.S., Hoffman I.F., Miller W.C. |
Depressive symptoms and use of HIV care and medication-assisted treatment among people with HIV who inject drugs |
AIDS |
|
Ukrainian Institute on Public Health Policy, Kyiv, Ukraine; School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States; Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States; Statistical Center for HIV/AIDS Research and Prevention (SCHARP), Fred Hutchinson Cancer Research Center, Seattle, WA, United States; College of Public Health, The Ohio State University, Columbus, OH, United States; UNC Vietnam, Ho Chi Minh City, Viet Nam; Abhipraya Foundation, Department Psychiatry, Faculty of Medicine, University of Indonesia, Depok, Indonesia; Family Health International (FHI 360), Durham, NC, United States; Indonesia National Narcotics Board, Abhipraya Foundation, East Jakarta, Indonesia; Johns Hopkins University, Baltimore, MD, United States; University of Pennsylvania, Philadelphia, PA, United States |
Lippincott Williams and Wilkins |
Article |
Q1 |
|
|
